Indications for red cell transfusion in sickle cell disease

Seminars in Hematology

Volumn 38, Issue 1 SUPPL. 1, 2001, Pages 5-13

  Ohene Frempong, Kwaku ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; ERYTHROCYTE TRANSFUSION; PRIORITY JOURNAL; RECURRENT DISEASE; SICKLE CELL ANEMIA; STROKE; TREATMENT INDICATION;

EID: 0035133221     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0037-1963(01)90055-1     Document Type: Conference Paper

References (73)

1. The use of transcranial ultrasonography to predict stroke in sickle cell disease
2. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography
3. Pulmonary entrapment of sickle cells: The role of regional alveolar hypoxia
4. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease
5. Post-angiographic blindness in a patient with sickle cell disease
6. The management of priapism in sickle cell anemia
7. Gadolinium-DOTA enhanced MRI of painful osseous crises in children with sickle cell anemia
8. The acute chest syndrome in sickle cell disease: Incidence and risk factors
9. A modified transfusion program for prevention of stroke in sickle cell disease
10. Prophylactic transfusions of normal red blood cells during pregnancies complicated by sickle cell hemoglobinopathies
11. Pregnancy and sickle cell hemoglobinopathies: Results with and without prophylactic transfusions
12. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease
13. Long-term blood transfusion in sickle-cell anemia
14. Acute splenic sequestration in homozygous sickle cell disease: Natural history and management
15. Priapism and impotence in homozygous sickle cell disease
16. Effect of transfusion in acute chest syndrome of sickle cell disease
17. The presentation, management and prevention of crisis in sickle cell disease in Africa
18. Priapism associated with the sickle cell hemoglobinopathies: Prevalence, natural history and sequelae
19. MR features of soft-tissue abnormalities due to acute marrow infarction in five children with sickle cell disease
20. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial
21. 99mTc penile scan: An investigative modality in priapism
22. Acute multiorgan failure syndrome: A potentially catastrophic complication of severe sickle cell pain episodes
23. Hemoglobinopathies in pregnancy
24. Silent cerebral infarcts in sickle cell anemia: A risk factor analysis
25. Use of erythrocytapheresis in the treatment of patients with sickle cell anemia
26. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study
27. Partial exchange transfusion in sickle cell anemia. Use in children with serious complications
28. Recurrent infections in homozygous sickle cell disease
29. Beneficial effect of blood transfusion in children with sickle cell chest syndrome
30. Management of sickle hemoglobinopathies in pregnant patients
31. Priapism in children with sickle cell disease
32. The use of prophylactic partial exchange tranfusion in pregnancies associated with sickle cell hemoglobinopathies
33. Surgery in patients with hemoglobin SC disease
34. Severe anaemia in children living in a malaria endemic area of Kenya
35. Stroke in sickle cell disease: Demographic, clinical, and therapeutic considerations
36. Cerebrovascular accidents in sickle cell disease: Rates and risk factors
37. Infections and immunizations of children with sickle cell disease
38. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions
39. Sickle cell chronic lung disease: Prior morbidity and the risk of pulmonary failure
40. The natural history of stroke in sickle cell disease
41. Neurologic events after partial exchange transfusion for priapism in sickle cell disease
42. Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke
43. Angiographic contrast agent-induced acute hemolysis in a patient with hemoglobin SC disease
44. Transient aplastic crisis in patients with sickle cell disease. B19 parvovirus studies during a 7-year period
45. The effect of ionic and nonionic contrast media on the sickling phenom
46. RBC exchange pheresis for priapism in sickle cell disease
47. Transfusion and alloimmunization in sickle cell disease
48. Transfusion therapy for cerebrovascular abnormalities in sickle cell disease
49. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease
50. Intensive transfusion therapy for priapism in boys with sickle cell anemia
51. Acute and chronic management of children with sickle cell anemia and cerebrovascular occlusive crisis
52. Acute splenic sequestration crises (ASSC) in young children with sickle cell anemia. Clinical observations in 20 episodes in 14 children
53. Human parvovirus infection in homozygous sickle cell disease
54. Sickle cell anemia with systemic lupus erythematosus: Response to hydroxyurea therapy
55. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome
56. Pregnancy in sickle cell disease
57. Parasitic infections in sickle cell crisis: Nigerian experience
58. Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI
59. Priapism - Pathogenesis and therapy
60. Sickle cell priapism. Therapeutic considerations in the light of 23 cases
61. Prophylactic blood transfusion in maternal sickle cell syndromes
62. Cerebral perfusion in children: Detection with dynamic contrast-enhanced T2*-weighted MR images
63. Acute chest syndrome in sickle cell disease: Clinical presentation and course
64. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease
65. The perioperative complication rate of orthopedic surgery in sickle cell disease
66. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease
67. Abnormalities of the central nervous system in very young children with sickle cell anemia
68. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents
69. Priapism
70. Experience with 105 patients with priapism: Update review of all aspects
71. Cerebrovascular abnormalities in pediatric stroke: Assessment using parenchymal and angiographic magnetic resonance imaging
72. Iodinated contrast agents in neuroradiology
73. Bacteremia in sickle hemoglobinopathies